Lazard Asset Management’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Buy
614,561
+603,170
+5,295% +$4.25M 0.01% 610
2026
Q1
$73.4K Sell
11,391
-18,981
-62% -$147K ﹤0.01% 1756
2025
Q4
$248K Buy
30,372
+18,903
+165% +$171K ﹤0.01% 1582
2025
Q3
$102K Sell
11,469
-139,907
-92% -$885K ﹤0.01% 1687
2025
Q2
$791K Buy
+151,376
New +$770K ﹤0.01% 1365
2024
Q2
Sell
-804
Closed -$2K 2227
2024
Q1
$2K Sell
804
-12,904
-94% -$31.2K ﹤0.01% 1931
2023
Q4
$36K Buy
+13,708
New +$26.1K ﹤0.01% 1976
2023
Q3
Sell
-15,950
Closed -$26K 2258
2023
Q2
$26K Buy
+15,950
New +$20K ﹤0.01% 2048

Other funds holding AVAH

Lazard Asset Management's AVAH Position: Q2 2026 in Review

Lazard Asset Management increased its Aveanna Healthcare (AVAH) stake by 5,295% in Q2 2026, buying an estimated $4.25M and bringing the position to 614,561 shares worth $5.27M. The position accounts for 0.01% of the portfolio, ranked #610.

Lazard Asset Management first reported a position in AVAH in Q2 2023 and has held it in 8 quarters since. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Lazard Asset Management held 614,561 shares of Aveanna Healthcare worth $5.27M as of Q2 2026.
  • Lazard Asset Management bought 603,170 Aveanna Healthcare shares in Q2 2026, an estimated $4.25M.
  • Aveanna Healthcare made up 0.01% of Lazard Asset Management's portfolio in Q2 2026, its #610 holding.
  • Lazard Asset Management first reported a position in Aveanna Healthcare in Q2 2023 and has held it in 8 quarters since.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.